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Summary.-Evidence is presented that microscopic tumours (of a transplantable
murine mammary carcinoma, M8013X) grow faster than larger, palpable, tumours.
Microscopic tumours are also more radiosensitive than larger tumours. The decrease
in radiosensitivity in larger tumours is prevented to a large extent by misonidazole,
which has no significant effect on the radiosensitivity of microscopic tumours. The
retardation in growth rate which occurs after the fast microscopic growth is probably
related to the appearance of hypoxic cells. Both the decrease in growth rate and the
progressive development of hypoxia may be caused by the relatively poorer blood
flow in larger tumours. Part of the radioresistance in "large" tumours (-250 mm3)
seems to be due to factors other than hypoxia; maybe cell-kinetic factors also play a
role. The intrinsic radiosensitivity of tumour cells in microscopic tumours was
assessed by means of a modified latency test: the Dq and Do were 2*2 and 2*5 Gy
respectively. Anumber offactors which may influence the reliability ofthese estimates
are discussed.
THE METABOLIC CONDITIONS and cell-
kinetic characteristics of a tumour appear
to change during its different growth
phases. This has been suggested as having
important repercussions on the effective-
ness ofanti-tumour agents such as ionizing
radiation and hyperthermia. The effects of
irradiation on a tumour would be in-
fluenced by the oxygenation status and the
cell kinetics. Some evidence already exists
that anoxic cells are absent from very
small tumours and only appear during
further growth (Suit et al., 1960; Reinhold
& de Bree, 1968; Shipley et al., 1975,
1976; Fu et al., 1976; Stanley et al.,
1978). It is very difficult to assess directly
the influence of the cell kinetics of a
tumour on its response to irradiation.
The irradiation of microscopic tumour
locations is common practice in clinical
radiotherapy, in what are usually called
elective or adjuvant treatments (Fletcher,
1971, 1972; Newton & Spittle, 1969; Breur
& Van der Schueren, 1979). The success
of such types of treatments could be due
to the relatively small number of cells to
be inactivated, but would still be enhanced
by a possible higher radiosensitivity of
the tumour cells in early phases ofgrowth.
In this study the radiosensitivity of a
microscopic tumour is tested by means of
a modified latency test (Clifton & Draper,
1963; Alfieri & Hahn, 1978). Moreover,
the effects of the anoxic-cell sensitizer
misonidazole (MISO) are studied. In this
way information is obtained about the
changes in radiosensitivity and the time
of appearance of hypoxic cells during
growth of a transplantable murine mam-
mary carcinoma in vivo. Apart from the
theoretical interest this would have prac-
tical implications, as it could provide
guidelines on whether or not to test the
possible usefulness ofanoxic cell sensitizers
for the radiotherapy of subclinical disease.
MATERIALS AND METHODS
The M8013 tumour originated in 1950 as a
mammary adenocarcinoma in a castratedRADIOSENSITIVITY OF MICROSCOPIC TUMOURS
oestrogen-stimulated male C57BL mouse at
the NKI (Nederlands Kanker Instituut) (Van
Dongen, 1961). The M8013X is a line derived
from this tumour, which is kept by serial
transplantation in male DBA2 x C57BL10
mice (obtained from the Centraal Proefdieren
Bedrijf TNO, Zeist, Netherlands). The
volume-doubling time ofthe M8013X tumour
is 16-1-8 days. In most experiments de-
scribed in this study, tumour implantation
was performed by s.c. injection of small
volumes, with a microlitre syringe, of a cell
suspension in the right hind leg of8-12-week-
old mice. To obtain a cell suspension, an
aseptically excised tumour was minced
thoroughly with scissors in 25 ml Eagle's
minimum essential medium supplemented
with 100 i.u./ml penicillin. The resulting cell
suspension was separated from the tumour
debris and the number of cells was counted,
using lyssamine green exclusion as a test for
viability. If necessary, the suspension was
concentrated by centrifugation (8 min, 120 g)
to a final concentration of 1-4 x 106 cells/ml.
The cell yield was 2-4% (assuming 5 x 108
cells/g of tumour tissue; Steel, 1977). Very
little clumping of cells was seen in the final
suspension.
Tumour size was measured 3-5 times a
week; tumour growth delay was determined
comparing the time necessary for controls
and treated animals to reach a tumour
volume of 1 cm3.
Irradiation was carried out by a Siemens
Stabilipan apparatus operating at 250 kV
and 14 mA, yielding a dose rate, after being
filtered by 0-5mm Cu, of 1-89 Gy/min at the
position of the tumour-bearing leg. Before
irradiation the mice were anaesthesized with
pentobarbitone sodium (Nembutal(®), 50 mg/
kg i.p.). The mice were kept at 30°C during
anaesthesia and shielded with lead, except
for the hind leg which protruded into the
beam.
RESULTS
Fig. 1 shows the effect of an irradiation
(8 Gy) of tumours implanted on the leg.
The tumour-bearing mice were irradiated
on different days after implantation of
3 x 104 tumour cells into the right hind
leg. About 10 days after s.c. injecting
3 x 104 cells, the tumours become palp-
able; 14 days after injection the tumour
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FIG. 1. The tumour growth delay caused by
X-irradiation (8 Gy) on different days after
implantation of 3 x 104 M8013X cells in the
hind leg ofmice (0) no MISO, ( 0) 0-5 mg/g
MISO injected 30 min before irradiation.
The numbers of animals per group were:
irradiated 1 day after implantation, with
or without MISO, 9; 4 days, 9; 7 days, 30;
10 days, 20; 12 days, 9; 14 days, 9; 13 days
with MISO, 9; 13 days without MISO, 5.
The error bars represent s.e.
volume is - 250 mm3. A significant drop
in radiosensitivity is found after about 10
days. The decrease in radiosensitivity is
prevented largely, but not completely,
by MISO.
Tumour growth delay caused. by irra-
diation can be correlated with the relative
survival of tumour cells, using a "titra-
tion" curve as in Fig. 2 (Alfieri & Hahn,
1978; Haveman et al., 1980). In this way
the "intrinsic" radiosensitivity of the
(microscopic) tumours can be assessed. In
a titration curve it is shown that implant-
ing lower cell numbers leads to an increase
in tumour growth delay. Irradiation of a
tumour leads to a reduction in cell number
and the extra time which is required by a
tumour to grow to a certain volume after
irradiation can be used to estimate this
reduction in cell number, by matching it,
on a titration curve, with the extra
tumour growth time due to implantation
of a certain lower cell number. In this
way survival curves can be obtained, as
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FIG. 2. Dependence of the tumour growth
time to a volume of 1 cm3 on the number of
dye-excluding M8013 cells injected in two
different locations: (0) s.c. in the hind leg
and (0) s.c. on the back. The numbers of
animals per group were: leg 10; back 20,
with the exception of the group receiving
3 x 105 cells (10). In brackets the number of
"takes" per group when not 100%. The
error bars represent s.e.
shown in Fig. 3. The titration curves in
Fig. 2 show also that:
(1) When lower cell numbers are
implanted, some oftheinjected mice failed
to develop a tumour ("no take") and
when "no takes" occur the titration curve
deviates from the straight line which canbe
drawn through the data points with 100%
takes.
(2) The tumour growth time to a certain
volume not only depends on the number of
cells implanted, but also on the site ofthe
implantation.
(3) From the slope of the curve of
tumour growth time against the logarithm
of the number of implanted cells, a doub-
ling time of 2*0 days is obtained. This
doubling time does not differ significantly
for the different sites of implantation.
From the measurements oftumour volume
during exponential growth on the leg
or the back, a doubling time of 1-6-1-8
days is obtained, which is slightly shorter
than the value from a "titration" curve.
Owing to the occurrence of "no takes" at
lower cell numbers in a titration curve,
the dose range in the survival curves (Fig.
3) which can be studied is limited. More-
over, the deviation from the straight line
when lower cell numbers are implanted
has to be taken into account. Titration
curves were repeated for each independent
experiment shown in Fig. 3 (10 animals
per treatment group).
The tumour growth time to 1 cm3
varies slightly between experiments; start-
ing from 105 cells injected s.c. into the
leg, the mean value is (19 independent
experiments, 10 animals each) 14-4 days,
standard deviation 1-7 days.
When M8013X cells were "titrated" on
the leg of pre-irradiated mice (5 Gy total
body 3 days before implantation) the
tumour growth times and the slope of the
resulting curve did not differ significantly
from a titration curve on animals without
treatment; "no takes" however appeared
only at lower numbers of cells injected.
As shown in Fig. 3, no significant dif-
ferences can be found in radiation sensi-
tivity, whether the cells were irradiated
before implantation or 4 h, 3 days and
10 days after implantation of 3 x 104 cells.
The same curve fits the data of Fig. 3(a)
and (b). The data in Fig. 3 confirm those
from the independent experiment shown
in Fig. 1. The decrease in radiosensitivity
at Day 10 in Fig. 1 is not, however, as
clear in Fig. 3(b); this may be due to the
spread in the data, or to slight variations
ingrowth timeto a certaintumourvolume,
starting with 3 x 104 cells in independent
experiments.
Dose-response curves, with and without
MISO, for tumours with a volume
250 mm3 are shown in Fig. 4(a). In
Fig. 4(b) the data of Fig. 4(a) are redrawn
so that they may be compared with the
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FIG. 3. The assumed relative survival of M8013X cells after X-irradiation. (a) ((O) irradiated before
implantation, (0) irradiated 4 h after implantation of 3 x 104 cells in the hind leg. Treatment
groups contained 8-10animals. (b) irradiated 4 h (0) (V), 3 days (A), or 10 days (0) after implant-
ation of 3 x 104 cells in the hind leg; (V) with MISO. The treatment groups consisted of 5-8
animals. TGD: tumour growth delay. The assumed relative survival is obtained by matching TGD
on a titration curve on the leg as described in the text.
data for the microscopic tumours. The
large tumours appear to be much more
radioresistant than microscopic tumours.
MISO enhances the radiosensitivity of the
250mm3 tumours, even at low doses, but
not completely to the level of the micro-
scopic tumours. The Dq and Do values
for microscopic tumours (Fig. 4(b)) are
2-2 and 2-5 Gy respectively, and for 250-
mm3 tumours without MISO 4-5 and 7 0
Gy, and with MISO 2-8 and 3-7 Gy respec-
tively.
DISCUSSION
Microscopic tumours ofM8013X appear
to be significantly more radiosensitive
than the (macroscopic) palpable tumours.
The relatively low radiosensitivity of the
large tumours can be enhanced consider-
ably by MISO. Very probably the radio-
resistance of the large tumours is thus at
least in part the result of the progressive
development of hypoxia in the tumour
during growth. Large tumours, even in the
presence of MISO, are more radioresistant
than microscopic tumours (Fig. 4(b)).
This may be due to cell-kinetic effects;
as the fraction of actively proliferating
cells could be decreased in these large
tumours. The dose-response curve (Fig. 4)
for 250mm3 tumours shows that these are
more radioresistant than microscopic
tumours, even at low doses. The effect of
the hypoxic cell sensitizer is also evident
at lower doses. This is very probably
because the hypoxic cell fraction in these
250mm3 tumours is very large. In the
mean time, we found that effects due to
hypoxia in larger tumours were further
enhanced by the Nembutal anaesthesia
(Wondergem et al., 1981). Similar effects
of Nembutal (for other tumours) have
been described by Denekamp et al. (1979).
The progressive development of hypoxia
during growth (Fig. 1) is presumably due
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FiG. 4. (a) The tumour growth delay caused by X-irradiation of palpable M8013X tumours
(, 250 mm3) located on the hind leg of mice: (0) without MISO, (0) 0 5 mg/g MISO injected i.p.
30 min before irradiation. 9-10 animals per treatment group. In (b) the data are replotted in such
a way that tumour growth delay in palpable tumours can be compared with the assumed relative
survival of microscopic tumours. The dashed curve is redrawn from Fig. 3.
to the relatively insufficient vasculariza-
tion of the tumour, compared to the
tumour growth rate. This apparently be-
comes evident at a certain tumour volume.
(When in our experiments the tumours
start to be palpable, tumour volume
< 50 mm3.)
The fact that the growth time to a cer-
tain tumour volume is dependent on the
site of implantation may be caused by
differences in lag time before cells start to
grow at the different sites, or by differen-
ces in take efficiency ofthe cells. A certain
fraction of cells may be lost upon implan-
tation, depending on the site of implanta-
tion. In the experiment shown in Fig. 2
the tumour growth time to 1 cm3 on the
leg and the back differs by 4-5 days (i.e.
2-2-2-8 doubling times) which may mean
that the take efficiency on the back is
15-20% of that on the leg.
It is important to consider differences in
tumour growth time at different sites. For
our experiments on the radiosensitivity
of microscopic tumours, implantation of
tumour cells was done as far as possible
on the same site on the lower leg, using a
small inoculum (25 pl).
In Fig. 3 the intrinsic radiosensitivity
of tumour cells in microscopic tumours is
assessed. A number of factors may limit
the reliability of an estimation of the
radiosensitivity in this way, the method
described may give a fair estimate for
microscopic tumours, but possibly not for
larger palpable tumours.
(1) The slightly longer doubling time
obtained from a "titration" curve (Fig. 2)
may lead to a slight underestimation ofthe
radiosensitivity, as a doubling time of 1*7
days may be taken as more realistic.
(2) Irradiation of tumours may lead to
fast regrowth (Van Peperzeel, 1970), an
effect which is difficult to evaluate in this
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model; again, a false estimate of the
radiosensitivity using the "titration" curve
may be the result. However, accelerated
regrowth after irradiation probably does
not play an important role in microscopic
tumours, which must be supposed to grow
already relatively fast (see below).
(3) The error due to cell-kinetic effects
during microscopic growth is apparently
not very large; there are no significant
changes in radiosensitivity during the first
7 days after inoculation.
(4) Effects due to irradiation of the
tumour-bed, in the dose range studied, are
probably not very large; there is no sig-
nificant difference in apparent relative
survival of cells irradiated before or after
implantation (Fig. 3) nor are there any
significant differences in tumour growth
delay during the first 7 days after inocula-
tion (Fig. 1).
(5) Cell loss, which may occur in large
tumours, is probably negligible in micro-
scopic tumours.
"Large" (250mm3) tumours (Fig. 4a)
are more radioresistant than the micro-
scopic tumours even at low doses, and
there is no clear break in the dose-response
curve (Jansen, 1980; Wondergem et al.,
1981); possibly the hypoxic cell fraction
in these tumours is at least 500o.
It has to be postulated that the doubling
time during microscopic growth is much
shorter than during macroscopic growth.
Even when it is assumed that all cells
injected contribute to growth, the tumour
growth time to 1 cm3 on the leg (1 cm3 is
assumed to contain , 5 x 108 malignant
cells) is very short, and cannot be ex-
plained by a volume-doubling time of 1-6-
1-8 days. A volume of 50 mm3 after
implantation of 105 cells on the leg is
reached in 7-8 days. From 50 mm3 to
1 cm3 (4.3 doublings) takes 7-0 days, which
means a doubling time of 1-7 days. For the
first 8 doublings to reach 50 mm3, each
doubling must have occurred in a maxi-
mum of 24 h. Cell lines derived from the
tumour, growing in vitro, had doubling
times of about 13 h, and a cell-cycle time
of 14.5 h has been described for the
M8013 tumour (Van Peperzeel, 1970).
From the slope of the curve of tumour
growth time against the logarithm of the
number of implanted cells (Fig. 2), a
doubling time of 2-0 days is obtained. The
fact that the doubling time from the slope
of the titration curve is in excess of 1-7
days probably means that microscopic
exponential growth when a smaller
number of cells is inoculated is dominated
only for a limited time by the fast growth,
a relatively large part of the microscopic
growthalreadyoccurringwiththedoubling
time of macroscopic growth, when a
smaller number of cells is inoculated.
Another possibility is that lower cell
numbers lead to a longer lag phase before
cell proliferation starts.
The retardation of growth rate which
occurs after the fast microscopic growth is
probably related to the appearance of a
hypoxic cell fraction, as assessed in Fig. 1.
In conclusion, it can be said that our
results further confirm that small tumours
are more radiosensitive than larger ones.
In larger tumours (with > 3 x 107 cells in
this model) the radioresistance may be
explained at least in part by the presence
of hypoxic cells, as the radioresistance
can be largely removed by MISO. Other,
such as cell-kinetic, factors are not ex-
cluded as large tumours, even in the
presence of hypoxic-cell sensitizer, are
more radioresistant than microscopic
tumours. Microscopic tumours grow faster
than larger tumours, the retardation in
growth rate occurring after the fast micro-
scopic growth being very probably related
to the appearance of hypoxic cells, prob-
ably caused by a relatively poor blood
flow in larger tumours. The method of
relating implanted cell numbers with
tumour growth time can be used to obtain
an estimate ofthe intrinsic radiosensitivity
of tumour cells in vivo over a limited dose
range. Fraction sizes normal to clinical
practice are well within the dose range
studied. However, one should be aware of
a number of factors which may limit the
direct applicability of the method to
larger palpable tumours.
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